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HIV or human immunodeﬁciency virus infection has assumed worldwide proportions and importance in just a span of 25 years.
Continuousresearchisbeingdoneinmanypartsoftheworldregardingitstreatmentandvaccinedevelopment,andalotofmoney
has ﬂown into this. However, fully understanding the mechanisms of immune depletion has still not been possible. The focus has
alsobeenonimprovingthequalityoflifeofpeoplelivingwithHIV/AIDSthrougheducation,counselling,andnutritionalsupport.
Malnutrition further reduces the capacity of the body to ﬁght this infection by compromising various immune parameters.
Knowledge of essential components of nutrition and incorporating them in the management goes a long way in improving quality
of life and better survival in HIV-infected patients.
1.Introduction
HIV accounts for signiﬁcant immunosuppression in an
infected individual. If the corroboratory indices of good
health are satisfactory, the suppression of immune defences
can be mitigated. One such index is nutrition. HIV, immune
expression, and nutrition interactions are complex and
related to each other. Malnutrition adds fuel to the ﬁre
by accelerating the progress of HIV infection to AIDS.
HIV/AIDSisassociatedwithbiologicalandsocialfactorsthat
aﬀect the individual’s ability to consume, utilize, and acquire
food.OncethereisaninfectionwithHIV,thepatient’snutri-
tional status declines further leading to immune depletion
and HIV progression.
2. Review of the Literature
Acquired immune deﬁciency syndrome, or AIDS, is a disease
caused by a retrovirus, the human immunodeﬁciency virus
(HIV), which attacks and impairs body’s natural defence
system against disease and infection. Malnutrition is deﬁned
as “the cellular imbalance between supply of nutrients and
energy and the body’s demand for them to ensure growth,
maintenance, and speciﬁc functions” [1]. Nutrition and
HIV are strongly related and complement each other. HIV
causes immune impairment leading to malnutrition which
leads to further immune deﬁciency, and contributes to rapid
progression of HIV infection to AIDS. A malnourished
person after acquiring HIV is likely to progress faster to
AIDS, because his body is weak to ﬁght infection whereas a
well-nourished person can ﬁght the illness better. It has been
proved that good nutrition increases resistance to infection
and disease, improves energy, and thus makes a person
stronger and more productive. Wasting syndrome is deﬁned
by loss of more than 10% of the usual body weight with a
lack of other detectable cause of wasting other than the HIV
infection itself [2]. Nutritional improvement measures must
be initiated before a patient reaches this stage.
2.1. Malnutrition in HIV. One of the factors responsible for
malnutrition in an HIV-infected person is reduced appetite,
which could be due to diﬃculty in ingesting food as a
result of infections like oral thrush or oesophagitis caused by
Candida, a common opportunistic infection in HIV-infected
people and fever, side eﬀects of medicines, or depression.
Poor absorption of nutrients may be due to accompanying
diarrhea which may be because of bacterial infections like
Salmonella or Mycobacterium avium intercellular;v i r a ll i k e
CMV or parasitic infections like Giardia, C. parvum,a n d
E. Bieneusi; due to nausea/vomiting as a side eﬀect of2 Clinical and Developmental Immunology
medications used to treat HIV or opportunistic infections.
30–50% of HIV patients in developed and nearly 90% in
developing countries complain of diarrhoea and malab-
sorption [3]. Gastrointestinal tract is the largest lymphoid
organ in the body and is directly aﬀected by HIV infection.
HIV causes damage to the intestinal cells by causing villus
ﬂattening and decreased D-xylose absorption. This leads to
carbohydrate and fat malabsorption thereby aﬀecting fat
soluble vitamins like vitamins A and E, which are important
for proper functioning of immune system. Whereas larger
amounts of nutrients are required during fever and infec-
tions that accompany an HIV infection, they are utilised
poorly by the body. This leads to loss of weight and lean
muscletissue,furthercausingdamagetotheimmunesystem.
Lack of iron in the diet and infections such as malaria
and hookworm lead to anaemia. Anaemia causes lethargy,
further reduces food intake and nutrient absorption, and
also causes disruption of metabolism, chronic infections,
muscle wasting, or loss in lean body tissue [4]. AIDS-related
dementia or neuropsychiatric impairment may make the
patientsunabletocareforthemselves,forgettoeat,orunable
to prepare balanced meals. Even in households with HIV-
infected members, nutritional impacts can be seen if the
infected adult becomes too sick to work and provide food for
themselvesandtheirfamilies[5,6].Dietaryintakealsovaries
inversely with level of virus, suggesting that viral replication
directly or indirectly suppresses appetite [7]. Malnutrition
is frequent and is considered a marker for poor prognosis
among HIV-infected subjects [8].
2.2. Immunology of HIV Infection. Both CD4+ and CD8+
T cells are important in controlling HIV infection. HIV
infection stimulates production of cytokines such as TNFα,
IL-6, IL-10, and IFNγ and a pool of activated target cells in
the lymphoid tissue which paradoxically help in establishing
andpropagatingHIVinfection.Rosenbergetal.[9]observ ed
thatHIV-speciﬁcCD4+T-cellresponseswereofhighmagni-
tude in individuals who were HIV infected but not showing
progression over long periods (long-term nonprogressors).
Also, in acute viral infections such responses could be seen
but they were generally not present in patients with chronic
progressive infections. In a small number of individuals who
began treatment shortly after acute HIV infection, HIV-
speciﬁc CD4+ T-cell responses were preserved. In addition,
these CD4+ T-cell responses seem to be important in
controllingviralreplicationaftersubsequentdiscontinuation
of antiretroviral therapy. However, it has also been found
that when discontinuation of antiretroviral therapy leads
to loss of virologic control, HIV-speciﬁc CD4+ T cells
are preferentially infected and depleted compared with
the CD4+ T cells of other antigen speciﬁcities. Antiviral
immunityinvolvesboththearmsoftheimmunesystem.The
protective component of cell-mediated immunity involves
the cytotoxic CD8 T-lymphocytes. Schmitz and colleagues
had demonstrated the eﬀects of CD8 T lymphocytes in
monkeys experimentally infected with simian immunodeﬁ-
ciency virus (SIV). They observed that prior to the depletion
of CD8+ T cells, SIV replication was well controlled but
after their depletion, control of viral replication was lost. In
some of these monkeys, when the CD8+ T cells regenerated,
the control of viral replication was regained [10]. Humoral
immunity to HIV is expressed by neutralising antibodies.
Anti-HIV antibodies are able to bind cell-free virus and
potentially prevent established infection in the challenged
host. Neutralising antibodies attaching to CD4 binding site
of HIV have been identiﬁed which appear to prevent the
virus from attaching to and infecting T cells. These are natu-
ral human antibodies—named VRC01, VRC02, and VRC03
which can neutralize over 90% of circulating HIV-1 isolates
[11]. Though HIV-speciﬁc humoral immune responses can
be detected during primary infection, they mostly comprise
low-avidity env speciﬁc IgG antibodies with little or no
neutralising activity [12]. Signiﬁcant neutralising titers are
believed to take place after chronicity has set in. HIV evolves
various strategies to establish chronicity in human body.
These include viral latency, inhibition of antigen processing
or presentation, mutations in viral epitopes, and rapid
clonal exhaustion/deletion of the initially expanded virus-
speciﬁc CD8+ CTL clones [13]. Initial CTL responses cause
downregulation of viremia and prevent disease progression,
but later it induces the selection of virus mutants capable of
escapingtheimmuneresponse[14].HIVvirionsconcentrate
on the surface of follicular dendritic cells in the germinal
centres of lymphoid organs from where they are shed
intermittently to establish a steady chronic state of infection
of CD4+ T cells, and to a chronic inﬂammatory reaction that
ultimately results in the destruction of lymphoid tissue [14].
Immune activation in HIV is supported by an experiment
by Pandrea et al. where induction of immune activation
was demonstrated in nonpathogenic SIV infection by an
increase in viral replication and CD4+ T-cell depletion in
gut associated lymphoid tissue [15]. Immune activation
is attributed to bystander activation in response to viral
products including gene products, immune response to HIV,
translocated microbial products, new viral target proteins,
epithelial or immune cells apoptosis, and/or self-antigens
[16]. High T-cell turnover in chronic HIV infection is
attributed to overlapping and nonsynchronized bursts of
proliferation, diﬀerentiation, and death in response to T-cell
receptor- (TCR-) mediated stimulation and inﬂammation
[16, 17]. Antiretroviral therapy (ART) results in a marked
reduction of T-cell activation and apoptosis and helps to
decreasenaiveT-cellconsumptionandrestoretheirnumbers
[18]. Chronic HIV infection also causes immunological or
direct virotoxic eﬀects on gastrointestinal tract which shows
blunted villi, crypt hyperplasia, and damaged epithelial
barrier with increased permeability and malabsorption of
bile acid and vitamin B12, microbial translocation, and
enterocyteapoptosis.Thereisadecreaseofluminaldefensins
and massive CD4 T-cell depletion but high concentration of
infected CD4 T cells [19].
2.3.ImmunologyofMalnutrition. Malnutritionisconsidered
to be the most common cause of immunodeﬁciency world-
wide [20]. Malnutrition, immune system, and infectious
diseases are interlocked in a complex negative cascade
[1]. Malnutrition elicits dysfunctions in the immune sys-
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infections [21]. These immune dysfunctions are referred
to as nutritional-acquired immune deﬁciency syndrome
(NAIDS). Every type of immunological deﬁciency induced
by malnutrition can be included under the NAIDS umbrella.
2.3.1.PEM. Protein-energymalnutrition(PEM),nowknown
as protein-energy undernutrition, is an energy deﬁcit due to
chronic deﬁciency of all macronutrients [22]. In children,
PEM causes widespread atrophy of lymphoid tissues, par-
ticularly T-lymphocyte areas. The thymus involutes causing
a reduction in the thymus-derived lymphocyte growth
and maturation factors, arrest of lymphocyte development,
reduced numbers of circulating mature CD4 helper cells,
and impairment of antibody production to T-dependent
antigens.ImbalanceinTh1-Th2activationoccursdepending
on nature of stimuli and altered regulatory pathways,
including responses mediated by the nuclear factor-kB (NF-
kB) [23], a major transcription factor involved in the
development of innate and adaptive immunity. Hence the
patient’s ability to ward oﬀ infections and show recovery is
compromised. However, CD8 suppressor cells are relatively
preserved. The lymphocytes not only get reduced in blood,
but also impaired show T-lymphocyte mitogenesis and
diminished activity in response to mitogens [24]. According
to Chandra [25], in children with PEM, there is a decrease
or reversal of the T-helper-suppressor cell ratio and total
numbersofT-lymphocytesdecreaseduetoreducednumbers
of these T-cell subpopulations. In malnourished children,
changes such as dermal anergy, loss of delayed dermal
hypersensitivity (DDH) reactions, and loss of the ability of
killer lymphocytes to recognize and destroy foreign tissues
were noted [20]. Necropsy studies on malnourished patients
have also shown profound depletion of the thymolymphatic
system and severe depression of cell-mediated immunity.
Chronic thymic atrophy with peripheral lymphoid tissue
wasting along with depletion of paracortical cells and loss of
germinalcentreswasnoted. This wassuggestedtohaveled to
varioustypes ofinfections fromwhichthesepatients actually
died [26].
B-lymphocyte numbers and functions generally appear
to be maintained though immunoglobulin concentrations
get reduced including secretory IgA (sIgA), which is respon-
sible for mucosal immunity. This may be due to increased
bacterial adherence to nasopharyngeal and buccal epithelial
cells or altered expression of membrane glycoprotein recep-
tors [27]. It has been speculated that the existing antibody
productionisconservedorevenincreasedduringgeneralized
malnutrition but new primary antibody responses to T-cell-
dependent antigens and antibody aﬃnity are impaired [20].
The failure of antibody formation is reversed within a few
days of protein therapy as amino acids become available
for the synthesis of immune proteins [28]. It also reduces
complementformation,andinterferonandlowerinterleukin
2r e c e p t o r s[ 26]. In patients with severe generalized malnu-
trition, functional status of the immune system should be
assessed by simply looking at the tonsils in young children.
In adequately nourished children they are usually huge but
are virtually undetectable in children with severe PEM.
This would indicate atrophy in the child’s thymus, spleen,
and lymph nodes, and severely compromised cell-mediated
immunity [24].
Deﬁciencies of other nutrients also adversely aﬀect the
immune mechanisms. Deﬁciencies of essential amino acids
can depress the synthesis of proteins responsible for pro-
duction of cytokines released by lymphocytes, macrophages,
and other body cells, complement proteins, kinins, clotting
factors, and tissue enzymes activated during acute phase
responses [24]. Arginine deﬁciency diminishes the produc-
tion of nitric oxide, and hence, the antioxidants, allowing
damaging eﬀects of free oxygen radicals [24]. Arginine has
also been shown to enhance phagocytes of alveolar macro-
phages, depress T suppressor cells, and stimulate T helper
cells [29]. The “nonessential” amino acid glutamine is
necessary for lymphocytes and other rapidly growing cells.
2.3.2. Essential Fatty Acids. Particularly the omega-3 fatty
acids, serve as the key precursors for the production of ei-
cosanoids like prostaglandins, prostacyclins, thromboxanes,
and leukotrines that play a variety of host defensive roles.
Thus their deﬁciency in the diet can impair cytokine synthe-
sis [30].
2.3.3. Vitamins. Vitamin A has an important role in nucleic
acid synthesis, and its deﬁciency is also characterized by lym-
phoid tissue atrophy, depressed cellular immunity, impaired
IgG responses to protein antigens, and pathologic alterations
of mucosal surfaces. Experimental animals with vitamin A
deﬁciency have decreased thymus and spleen sizes, reduced
natural killer cell, macrophage and lymphocyte activity,
lower production of interferon, and weak response to
stimulationbymitogens[31].B-groupvitaminslikethiamin,
riboﬂavin,pantothenicacid,biotin,folicacid,andcobalamin
can inﬂuence humoral immunity by diminishing antibody
production. Pyridoxine deﬁciency has also been associated
withreducedcell-mediatedimmunity.Folicacidandvitamin
B-12 are essential to cellular replication. Experimental
deﬁciencies of these vitamins were shown to interfere with
both replication of stimulated leukocytes and antibody for-
mation. In anemia due to folic acid deﬁciency, cell-mediated
immunity is depressed [32]. In vitamin C deﬁciency,
phagocytic cells cannot produce tubulin, therefore, with
impaired chemotaxis, microorganisms cannot be engulfed
and destroyed [33]. Vitamin D acts as an immunoregulatory
andalymphocytediﬀerentiationhormone[34].InvitaminE
deﬁciency,leukocyteespeciallylymphocytekillingpowergets
reduced. In animals it was shown to interfere with antibody
formation, plaque-forming cells, and other aspects of cell-
mediated immunity. At higher than recommended levels, it
has been shown to enhance immune response and resistance
to disease [35].
2.3.4. Minerals. Zinc is also the fundamental component of
thymic hormones and shares a similar role as vitamin A in
nucleic acid synthesis. Zinc deﬁciency inﬂuences both lym-
phocyte and phagocyte cell functions and aﬀects more than
100 metalloenzymes that are zinc dependent [36]. During
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blood and phagocytes release lactoferrin with a higher iron
bindingcapacitythanbacterialsiderophores.Theneteﬀectis
to deprive the infectious agent of iron for its replication and
inhibit the spread of infection [34]. Iron deﬁciency results
in impaired phagocytic killing, less response to lymphocyte
stimulation, fewer natural killer cells, and reduced interferon
production [37]. Selenium serves as an antioxidant and
contributes to antibody responses and cytotoxicity of natural
killer cells [38]. In children with HIV infection, selenium
concentration in plasma appeared to correlate with their
immune functions [39]. Similar changes were also seen in
patients with copper deﬁciency [40]. Copper concentrations
often increase during infection as a result of stimulation
of the hepatic production of ceruloplasmin. Conversely,
plasma zinc concentration often declines due to internal
redistribution to the liver. Antimicrobial systems in the
neutrophils are aﬀected by malnutrition. These include both
oxygen-dependent systems responsible for the respiratory
burst, and oxygen-independent systems, such as lactoferrin,
lysozymes, hydrolase, and proteases [34].
2.4. Cytokine Abnormalities in HIV and/or Malnutrition.
Cytokines are substances that play an important role in
coordinating inﬂammatory response of the body to various
external and internal stimuli. They may be proinﬂamma-
tory, which are essential to initiate defence against various
pathogens, and anti-inﬂammatory, which downregulate the
inﬂammatory process by suppressing production of the
proinﬂammatory cytokines and balance the inﬂammatory
response. Excess production of both are counterproductive.
The proinﬂammatory cytokines include IL-1β,I L - 6 ,I L -
8, TNF-α, and IL-2, and the anti-inﬂammatory cytokines
include IL-1 receptor antagonist, IL-4, IL-10, and IL-13
[41]. PEM diminishes immunoglobulin (IgA, IgM, and
IgG) concentrations and cytokine production [34]. Severe
malnutrition alters the ability of T lymphocytes to respond
appropriately to IL-1 rather than simply aﬀecting synthesis
of this monokine [42]. During catabolic states, interleukin
1 is released by leukocytes which causes endocrine changes
that lead to amino-acid mobilization, primarily from skeletal
muscle. These amino acids are used for gluconeogenesis
in the liver, and the nitrogen released is excreted in urine
[43]. Thus, a continual conversion of alanine carbon to
glucose carbon occurs with acute infection. Bell et al. [44]
observed that the immunosuppressive PGE2 production was
enhancedinmalnutrition.InmalnourishedAfricanswithout
overt infections, increased circulating levels of inﬂammatory
mediators (e.g., interleukin 6 (IL-6), the soluble receptors of
tumor necrosis factor (sTNFR-p55 and sTNFR-p75), etc.) as
well as C-reactive protein, were seen compared to healthy
controls[45].InHIVinfection,bothCD4+andCD8+Tcells
secrete interferon-γ (IFN-γ) in response to antigen-speciﬁc
stimulation. Another cytokine, tumor necrosis factor has
been suggested as a potential etiologic factor in HIV wasting
syndromeasithasbeenincriminatedasanappetiteinhibitor
[46].
2.5. Combined Eﬀect of HIV and Malnutrition on the Immune
System. Malnutrition and HIV form a vicious cycle and
ultimately aim at reducing the immunity of the patient. In
both malnutrition and HIV there is reduced CD4 and CD8
T-lymphocyte numbers [47], delayed cutaneous sensitivity,
reduced bacteriocidal properties [24], and impaired serolog-
ical response after immunizations. Some of the immuno-
logical parameters concerning these two entities have been
listed in Table 1. According to a study, approximately 30–
60% of asymptomatic children infected with HIV malabsorb
carbohydrates, 30% malabsorb fat, and 32% malabsorb
proteins [48, 49]. Whereas micronutrient deﬁciencies may
aﬀect replication of the invading virus, they also induce
several metabolic alterations in the body. This includes
changes in whole-body protein turnover, increased urinary
nitrogen loss, and elevated hepatic protein synthesis as
well as increased skeletal muscle breakdown providing for
proliferation of neutrophils, lymphocytes, and ﬁbroblasts,
and for synthesis of immunoglobulins and hepatic acute
phase proteins, manifesting clinically as fever. It also includes
hypertriglyceridemia, elevated hepatic de novo fatty acid
synthesis, decreased peripheral lipoprotein lipase activity,
hyperglycemia, insulin resistance, and increased gluconeoge-
nesis.Serumconcentrationsofironandzincfalldramatically
due to redistribution within the body, with accumulation
in the liver [50]. Glutathione, which is the principle intra-
cellular antioxidant, was reported to be reduced in children
with HIV infection, especially those showing growth failure
[51].
During infections, reactive oxygen molecules and pro-
oxidant cytokines are released from activated phagocytes
[56] leading to increased consumption of vitamins like
vitamin E and C, and β-carotene which serve as antioxidants
and minerals like zinc, copper, manganese, and selenium,
which serve as components of antioxidant enzymes [57].
Deﬁciencies of antioxidants cause increased oxidative stress
whichleadstoapoptosisofTcellsandindirectlycompromise
cell-mediated immunity and may stimulate HIV replication.
In cell cultures, HIV replication was shown to be inhibited
by various antioxidants but stimulated by reactive oxygen
radicals via activation of nuclear transcription factor cell
gene [58]. This oxidative burst may also increase viral
load of blood and body ﬂuids, such as seminal ﬂuid
and cervicovaginal secretions, and thus increase infectivity.
Maternal micronutrient deﬁciencies may also increase viral
load in blood, cervicovaginal secretions, and breast milk,
and hence aid in utero, intrapartum, and postnatal mother-
to-child HIV transmission, respectively, and aﬀect immune
functions and susceptibility of the unborn or young breast-
fed child. HIV infection in nutritionally deprived individuals
intensiﬁesthenutritionaldeﬁcitsandfurtherenhancescellu-
lar oxidative stress. This aﬀects the functions of transcription
factors as NF-kB and contributes to HIV replication and
progression. Although HIV attacks only a limited variety of
T-lymphocyte subspecies, AIDS-induced malnutrition can
lead to the secondary development of NAIDS through the
action of proinﬂammatory cytokines. Also, malnutrition
could hasten the development of AIDS in an HIV-infected
person [24].
Speciﬁc micronutrient deﬁciencies may also favour the
host and supplementation favour the virus. For example,Clinical and Developmental Immunology 5
Table 1: Comparison of eﬀects of HIV infection and malnutrition on various parameters of the immune system [20, 24, 47, 52–55].
Immunological parameter Eﬀect of HIV infection Eﬀe c to fm a l n u t r i t i o n N u t r i e n td e ﬁ c i e n c y
Total lymphocytes Decreased Decreased PEM
T lymphocytes Decreased Decreased PEM
CD4 T lymphocytes Decreased Decreased PEM
CD8 T lymphocytes Transient increase, then
decrease Relatively maintained —
CD4: CD8 T-cell ratio Inverted Reversed PEM
Lymphocyte responsiveness to mitogens/antigens Reduced Reduced PEM, vitamin A, E, zinc,
iron
Cell-mediated immunity Compromised Compromised PEM, essential amino acids
(pyridoxine)
B lymphocytes Polyclonal activation Generally maintained —
Immunoglobulin levels Increased (IgA, IgG) Reduced (IgA, IgG, IgM) PEM, amino acids, vitamin
Bc o m p l e x
Secretory IgA (sIgA) Increased Decreased PEM
B-cell activity Reduced Reduced PEM,
Primary antibody responses Reduced Reduced PEM
Antibody aﬃnity Decreases with increase
in HIV progression Reduced PEM
NK cell activity Increased Reduced Vitamin A, C, zinc, iron,
selenium
Serum complement Increased Reduced PEM, essential amino acids
Serum β-2 microglobulin Increased, marker of
HIV progression Increased PEM
IFN-γ Increased Reduced Amino acids, essential fatty
acids, iron
TNF-α, IL-6 Increased Increased PEM
Anti-inﬂammatory Cytokines (IL-4) Reduced Increased PEM
Soluble IL-2 receptors Increased Reduced PEM
Antioxidants Reduced Reduced
Essential amino acids
(arginine), selenium, zinc,
manganese, copper,
vitamins A, C, E
C-reactive protein Increased, marker of
HIV disease progression Increased PEM
HIV replication was enhanced in monocytes cultured with
retinoid [59]. Similarly, HIV nucleocapsid protein binds zinc
and forms zinc ﬁnger structures. This might imply that
a high zinc intake increases the replication of HIV [60].
The role of iron in HIV infection is more complex, since
iron is important for optimal immune function, and is also
a pro-oxidant and may promote replication, as has been
shown following a U-shaped curve in laboratory studies
[61]. Though antioxidants inhibit HIV replication, they
may actuallypromote opportunistic infections by preventing
the oxidative burst which is considered important for the
bactericidal properties of phagocytes [56]. So, balanced
nutrition and dietary consultation with experts helps in
balancing immune eﬀects, malnutrition, and HIV infection.
FAO [62] had stated “Food is not a magic bullet. It won’t
stop people from dying of AIDS but it can help them live
longer, more comfortable and productive lives.” Evidence-
based nutrition interventions should be part of all national
HIV care and treatment programmes. Routine assessment
should be made of diet and nutritional status (weight and
weight change, height, body mass index or midupper arm
circumference, and symptoms and diet) for people living
with HIV [63].
Baum et al. [64] had concluded that “intake of nutrients
at levels recommended for the general population does
not appear to be adequate for HIV-1-infected patients’.”
An active non-HIV-infected adult requires approximately
2070kcal/day including about 57grams/day of protein. An
HIV-infected adult requires 10 to 15 percent more energy
per day and approximately 50 to 100 percent more protein
[65, 66]. Diet given to such patients should be rich in
carbohydrates, proteins, vitamins, and minerals. A dietician
should be involved in guiding the patients or their rela-
tives to prepare nutritious foods. In developing countries,
micronutrientsupplementationtohigh-riskpopulationscan
be provided via the primary health care system.6 Clinical and Developmental Immunology
Since the realization of HIV as a potential disaster for
the immune system, several advancements in its treatment,
diagnosis, and supportive regimens have been made, still
many deaths in AIDS are being attributed to malnutri-
tion and its poor management. Biochemical evaluation of
the nutritional status must be done in AIDS patients by
testing blood haemoglobin and haematocrit and serum
levels of cholesterol, total protein, albumin, and transferrin.
Nutritional counselling and support could delay or even
prevent the development of NAIDS and could improve both
the quality and length of their lives. Therefore, early and
intensive dietary interventions should be a fundamental part
of the case management of HIV-infected individuals at the
level of ART centre itself.
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